Selected research
Industry Growth & Trends
Global Valbenazine API Industry Growth and Trends Forecast to 2032
Market perspective
The global Valbenazine API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Valbenazine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Valbenazine API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Valbenazine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Valbenazine API include Zhejiang Hengtengfu Pharmaceutical, Shaanxi Dideu Medichem, Nantong HI-FUTURE Biology, Jiangxi LongLife Bio-pharmaceutical, Jiangsu Vcare PharmaTech, Chengdu Miracle Pharmaceutical, SynZeal Research, MSN Laboratories and Lupin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Valbenazine API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Valbenazine API market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Valbenazine API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Valbenazine API.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Valbenazine API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Valbenazine API Market by Company
Zhejiang Hengtengfu Pharmaceutical
Shaanxi Dideu Medichem
Nantong HI-FUTURE Biology
Jiangxi LongLife Bio-pharmaceutical
Jiangsu Vcare PharmaTech
Chengdu Miracle Pharmaceutical
SynZeal Research
MSN Laboratories
Lupin
Acharya Chemical
Valbenazine API Segment by Type
Purity ≥ 98%
Purity ≥ 99%
Valbenazine API Segment by Application
Online Sales
Offline Sales
Valbenazine API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valbenazine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Valbenazine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valbenazine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Valbenazine API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Valbenazine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥ 98%
- Purity ≥ 99%
Applications
- Online Sales
- Offline Sales
Companies covered
- Zhejiang Hengtengfu Pharmaceutical
- Shaanxi Dideu Medichem
- Nantong HI-FUTURE Biology
- Jiangxi LongLife Bio-pharmaceutical
- Jiangsu Vcare PharmaTech
- Chengdu Miracle Pharmaceutical
- SynZeal Research
- MSN Laboratories
- Lupin
- Acharya Chemical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Valbenazine API Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Valbenazine API Sales Estimates and Forecasts (2021-2032)
- 1.3 Valbenazine API Market by Type
- 1.3.1 Purity ≥ 98%
- 1.3.2 Purity ≥ 99%
- 1.4 Global Valbenazine API Market Size by Type
- 1.4.1 Global Valbenazine API Market Size Overview by Type (2021-2032)
- 1.4.2 Global Valbenazine API Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Valbenazine API Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Valbenazine API Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Valbenazine API Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Valbenazine API Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Valbenazine API Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Valbenazine API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Valbenazine API Industry Trends
- 2.2 Valbenazine API Industry Drivers
- 2.3 Valbenazine API Industry Opportunities and Challenges
- 2.4 Valbenazine API Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Valbenazine API Revenue (2021-2026)
- 3.2 Global Top Players by Valbenazine API Sales (2021-2026)
- 3.3 Global Top Players by Valbenazine API Price (2021-2026)
- 3.4 Global Valbenazine API Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Valbenazine API Major Company Production Sites & Headquarters
- 3.6 Global Valbenazine API Company, Product Type & Application
- 3.7 Global Valbenazine API Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Valbenazine API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Valbenazine API Players Market Share by Revenue in 2025
- 3.8.3 2025 Valbenazine API Tier 1, Tier 2, and Tier 3
4 Valbenazine API Regional Status and Outlook
- 4.1 Global Valbenazine API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Valbenazine API Historic Market Size by Region
- 4.2.1 Global Valbenazine API Sales in Volume by Region (2021-2026)
- 4.2.2 Global Valbenazine API Sales in Value by Region (2021-2026)
- 4.2.3 Global Valbenazine API Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Valbenazine API Forecasted Market Size by Region
- 4.3.1 Global Valbenazine API Sales in Volume by Region (2027-2032)
- 4.3.2 Global Valbenazine API Sales in Value by Region (2027-2032)
- 4.3.3 Global Valbenazine API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Valbenazine API by Application
- 5.1 Valbenazine API Market by Application
- 5.1.1 Online Sales
- 5.1.2 Offline Sales
- 5.2 Global Valbenazine API Market Size by Application
- 5.2.1 Global Valbenazine API Market Size Overview by Application (2021-2032)
- 5.2.2 Global Valbenazine API Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Valbenazine API Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Valbenazine API Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Valbenazine API Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Valbenazine API Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Valbenazine API Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Valbenazine API Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zhejiang Hengtengfu Pharmaceutical
- 6.1.1 Zhejiang Hengtengfu Pharmaceutical Company Information
- 6.1.2 Zhejiang Hengtengfu Pharmaceutical Business Overview
- 6.1.3 Zhejiang Hengtengfu Pharmaceutical Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zhejiang Hengtengfu Pharmaceutical Valbenazine API Product Portfolio
- 6.1.5 Zhejiang Hengtengfu Pharmaceutical Recent Developments
- 6.2 Shaanxi Dideu Medichem
- 6.2.1 Shaanxi Dideu Medichem Company Information
- 6.2.2 Shaanxi Dideu Medichem Business Overview
- 6.2.3 Shaanxi Dideu Medichem Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shaanxi Dideu Medichem Valbenazine API Product Portfolio
- 6.2.5 Shaanxi Dideu Medichem Recent Developments
- 6.3 Nantong HI-FUTURE Biology
- 6.3.1 Nantong HI-FUTURE Biology Company Information
- 6.3.2 Nantong HI-FUTURE Biology Business Overview
- 6.3.3 Nantong HI-FUTURE Biology Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Nantong HI-FUTURE Biology Valbenazine API Product Portfolio
- 6.3.5 Nantong HI-FUTURE Biology Recent Developments
- 6.4 Jiangxi LongLife Bio-pharmaceutical
- 6.4.1 Jiangxi LongLife Bio-pharmaceutical Company Information
- 6.4.2 Jiangxi LongLife Bio-pharmaceutical Business Overview
- 6.4.3 Jiangxi LongLife Bio-pharmaceutical Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Jiangxi LongLife Bio-pharmaceutical Valbenazine API Product Portfolio
- 6.4.5 Jiangxi LongLife Bio-pharmaceutical Recent Developments
- 6.5 Jiangsu Vcare PharmaTech
- 6.5.1 Jiangsu Vcare PharmaTech Company Information
- 6.5.2 Jiangsu Vcare PharmaTech Business Overview
- 6.5.3 Jiangsu Vcare PharmaTech Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Jiangsu Vcare PharmaTech Valbenazine API Product Portfolio
- 6.5.5 Jiangsu Vcare PharmaTech Recent Developments
- 6.6 Chengdu Miracle Pharmaceutical
- 6.6.1 Chengdu Miracle Pharmaceutical Company Information
- 6.6.2 Chengdu Miracle Pharmaceutical Business Overview
- 6.6.3 Chengdu Miracle Pharmaceutical Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Chengdu Miracle Pharmaceutical Valbenazine API Product Portfolio
- 6.6.5 Chengdu Miracle Pharmaceutical Recent Developments
- 6.7 SynZeal Research
- 6.7.1 SynZeal Research Company Information
- 6.7.2 SynZeal Research Business Overview
- 6.7.3 SynZeal Research Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 SynZeal Research Valbenazine API Product Portfolio
- 6.7.5 SynZeal Research Recent Developments
- 6.8 MSN Laboratories
- 6.8.1 MSN Laboratories Company Information
- 6.8.2 MSN Laboratories Business Overview
- 6.8.3 MSN Laboratories Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 MSN Laboratories Valbenazine API Product Portfolio
- 6.8.5 MSN Laboratories Recent Developments
- 6.9 Lupin
- 6.9.1 Lupin Company Information
- 6.9.2 Lupin Business Overview
- 6.9.3 Lupin Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Lupin Valbenazine API Product Portfolio
- 6.9.5 Lupin Recent Developments
- 6.10 Acharya Chemical
- 6.10.1 Acharya Chemical Company Information
- 6.10.2 Acharya Chemical Business Overview
- 6.10.3 Acharya Chemical Valbenazine API Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Acharya Chemical Valbenazine API Product Portfolio
- 6.10.5 Acharya Chemical Recent Developments
7 North America by Country
- 7.1 North America Valbenazine API Sales by Country
- 7.1.1 North America Valbenazine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Valbenazine API Sales by Country (2021-2026)
- 7.1.3 North America Valbenazine API Sales Forecast by Country (2027-2032)
- 7.2 North America Valbenazine API Market Size by Country
- 7.2.1 North America Valbenazine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Valbenazine API Market Size by Country (2021-2026)
- 7.2.3 North America Valbenazine API Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Valbenazine API Sales by Country
- 8.1.1 Europe Valbenazine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Valbenazine API Sales by Country (2021-2026)
- 8.1.3 Europe Valbenazine API Sales Forecast by Country (2027-2032)
- 8.2 Europe Valbenazine API Market Size by Country
- 8.2.1 Europe Valbenazine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Valbenazine API Market Size by Country (2021-2026)
- 8.2.3 Europe Valbenazine API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Valbenazine API Sales by Country
- 9.1.1 Asia-Pacific Valbenazine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Valbenazine API Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Valbenazine API Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Valbenazine API Market Size by Country
- 9.2.1 Asia-Pacific Valbenazine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Valbenazine API Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Valbenazine API Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Valbenazine API Sales by Country
- 10.1.1 South America Valbenazine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Valbenazine API Sales by Country (2021-2026)
- 10.1.3 South America Valbenazine API Sales Forecast by Country (2027-2032)
- 10.2 South America Valbenazine API Market Size by Country
- 10.2.1 South America Valbenazine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Valbenazine API Market Size by Country (2021-2026)
- 10.2.3 South America Valbenazine API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Valbenazine API Sales by Country
- 11.1.1 Middle East and Africa Valbenazine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Valbenazine API Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Valbenazine API Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Valbenazine API Market Size by Country
- 11.2.1 Middle East and Africa Valbenazine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Valbenazine API Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Valbenazine API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Valbenazine API Value Chain Analysis
- 12.1.1 Valbenazine API Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Valbenazine API Production Mode & Process
- 12.2 Valbenazine API Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Valbenazine API Distributors
- 12.2.3 Valbenazine API Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst